tiprankstipranks
TipRanksTop Financial ExpertsInsidersCarmen Chang

Carmen Chang Insider Profile

11 Followers
Carmen Chang, Director at Coursera, holds 2.33M shares in Coursera (Ticker: COUR), holds 1.30M shares in Korro Bio (Ticker: KRRO), holds 7.39M shares in SpyGlass Pharma (Ticker: SGP).
See the Hottest Stocks Based on Insider Trading >
tipranks
Carmen Chang

Carmen Chang
Coursera (COUR)
Director

Ranked #103,293 out of 108,921 Corporate Insiders

Profitable Transactions

26%
5 out of 19 Profitable Transactions

Average Return

-29.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$1B
19.90%
19.68%
19.08%
17.50%
23.84% Others
A breakdown of Carmen Chang's holdings
See the Top Stocks by Insiders

Insider Roles

MBX Biosciences, Inc.
(MBX)
Ten Percent Owner
Mirum Pharmaceuticals
(MIRM)
Ten Percent Owner
SpyGlass Pharma
(SGP)
Ten Percent Owner
Trevi Therapeutics
(TRVI)
Ten Percent Owner
+4 other positions
Roles that Carmen Chang holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Jul 24, 2019 - Jul 24, 2020
Return:+47.80%
The most profitable trade made by Carmen Chang
See the Latest Stocks Traded by Insiders

Carmen Chang's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
COUR
Coursera
Jun 15, 2026
Director
Uninformative Buy
―
$13.50M
SVRA
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$131.41M
KRRO
Korro Bio
Mar 12, 2026
Ten Percent Owner
Informative Buy
2.30M
$15.89M
MBX
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
―
$223.09M
SGP
SpyGlass Pharma
Feb 11, 2026
Ten Percent Owner
Uninformative Buy
―
$213.93M
GNCAQ
Genocea Biosciences
May 26, 2022
―
Informative Sell
711.52K
―
RGLS
Regulus
May 09, 2019
―
Informative Buy
1.23M
$16.75M
TRVI
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$196.25M
MIRM
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Sell
―
$220.61M
AKUS
AKOUOS
Dec 02, 2022
―
Uninformative Sell
―
$0.00
MTCR
Metacrine
Dec 27, 2021
―
Informative Sell
493.91K
$1.49M
GLUE
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
―
$106.46M
NEUE
NeueHealth Inc
Oct 06, 2025
―
Uninformative Buy
6.81K
$0.00
List of latest transactions for each holding click on a transaction to see Carmen Chang's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Carmen Chang insider profile FAQ

What is the percentage of profitable transactions made by Carmen Chang?
The percentage of profitable transactions made by Carmen Chang is 26%.
    What is the average return per transaction made by Carmen Chang?
    The average return per transaction made by Carmen Chang is -29.50%.
      What stocks does Carmen Chang hold?
      Carmen Chang holds: COUR, SVRA, KRRO, MBX, SGP, GNCAQ, RGLS, TRVI, MIRM, AKUS, MTCR, GLUE, NEUE stocks.
        What was Carmen Chang’s latest transaction?
        Carmen Chang latest transaction was an Uninformative Buy of ―.
          What was Carmen Chang's most profitable transaction?
          Carmen Chang’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
            What is Carmen Chang's role in Coursera?
            Carmen Chang's role in Coursera is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.